the aid library

ZAZI: a participatory programme on Sexual and Reproductive Health for women and girls - a toolkit for facilitators
recommended

Durden E.; M.Gumede John Hopkins Health and Eduaction, South Africa; USAID; et al. (2016) CC

This toolkit has been developed by the ZAZI campaign for use by peer educators, community outreach workers, faith-based organisations, and traditional health practitioners to help facilitate participatory discussions on sexual and reproductive health with women aged between 20 and 49 years of age. T... more

Download (340)

View PDF (548)

Indigenous peoples

M. Smelyanskaya, C. Daniels, et al. Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief.

Download (237)

View PDF (425)

Integrating mental health into South Africa’s health system: current status and way forward

Schneider, M.; E. Baron, E. Breuer, et al. (2016) CC

Download (547)

View PDF (714)

Money and Mosquitoes: The Economics of Malaria in an Age of declining Aid

Eric Maskin, Célestin Monga, Josselin Thuilliez and others African Development Bank (2018) C1

(African Development Bank policy research document 1)
The report examines financing in the battle against malaria, focusing on the role of foreign aid. It analyzes whether or not a disease such as malaria can be controlled or eliminated in Africa without health aid. It also presents a theoretic... more

Download (257)

View PDF (382)

Rural populations (Russian edition)

Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief Accessed 2017 СЕЛЬСКОЕ НАСЕЛЕНИЕ ОСНОВНЫЕ ЗАТРОНУТЫЕ ГРУППЫ НАСЕЛЕНИЯ. КРАТКОЕ РУКОВОДСТВО.

Download (181)

View PDF (209)

сельское население (rural- russian edition)

FG Consulting Group, C. Daniels, C. Smyth et al. UNOPS, Stop TB Partnership et al. (2019) C1

Глобальная статистика свидетельствует о том, что бремя туберкулеза более актуально в городских регионах. Тем не менее, в тех странах, где большая часть населения п�... more

Interim Guidance on the Use of Rapid Antibody Tests for COVID-19 Response
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2020) CC

The speed of developing diagnostics for SARS-CoV-2, the causative agent of coronavirus disease 2019 (COVID-19), has been quite remarkable. Diagnostics have focused on nucleic acid amplification testing (NAAT) to identify infected individuals in acute-phase disease for timely implementation of mitiga... more

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (2312)

View PDF (3308)

Standard Treatment Guidelines and Essential Medicines List for South Africa. Hospital Level: Paediatrics

Department of Health, Republic of South Africa (2017) C1

Fourth Edition

Standard Treatment Guidelines and Essential Medicines List for South Africa - Hospital Level Adults 2nd Edition - 2019

National Department of Health South Africa (2020) CC

The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th... more

Сводное руководство ВОЗ по туберкулезу. Модуль 4: лечение. Лечение лекарственно-устойчивого туберкулеза‎

World Health Organization WHO (2021) C_WHO

Download (467)

View PDF (699)

Treatment of tuberculosis - Annex 5 Reports of the systematic reviews

World Health Organization (2017) C_WHO

Guidelines for treatment of drug-susceptible tuberculosisand patient care 2017 Update

Download (284)

View PDF (452)

Rural populations

Stop TB Partnership; UNOPS; END TB (2017) C1

Key populations brief Accessed 2017

Download (332)

View PDF (374)

Populations Rurales - En situation de pauvreté

Stop TB Partnership; UNOPS; END TBc1 (2017) C1

Rapport sur les populations clès Accessed November 2017

Download (362)

View PDF (367)

Poblaciones rurales - En situación de probreza

Stop TB Partnership; UNOPS; END TB (2017) C1

Informe sobre poblaciones clave

Download (193)

View PDF (224)

WHO consolidated guidelines on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment,update

World Health Organization WHO (2022) C_WHO

These guidelines group all recommendations on TB care and support in one document and are complemented by an operational handbook. The guidelines are to be used primarily by national TB programmes, or their equivalents in Ministries of Health, stakeholders and technical organizations working on... more

Download (451)

View PDF (642)

South Africa’s protracted struggle for equal distribution and equitable access – still not there

Hendrik CJ van Rensburg (2014) CC

Download (191)

View PDF (398)

Towards a tuberculosis-free world

International Federation of Red Cross and Red Crescent Societies; Stop TB Partnership (2011) C1

Advocacy report March 2011 303100 03/2011 E 1,000

Download (219)

View PDF (318)

Pour en finir avec la tuberculose

Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge; Stop TB Partnership (2011) C2

Rapport de plaidoyer Mars 2011 303100 03/2011 E 1,000

ZAZI: a participatory programme on Sexual and Reproductive Health for women and girls - a toolkit for facilitators recommended

Interim Guidance on the Use of Rapid Antibody Tests for COVID-19 Response recommended

ZAZI: a participatory programme on Sexual and Reproductive Health for women and girls - a toolkit for facilitators
recommended

Interim Guidance on the Use of Rapid Antibody Tests for COVID-19 Response
recommended